TEOSYAL® PURESENSE REDENSITY I (1x3ml)

Product Overview: TEOSYAL® PURESENSE REDENSITY I (1x3ml)

TEOSYAL® PURESENSE REDENSITY I (1x3ml) is a sterile, non-pyrogenic, viscoelastic gel formulated for skin revitalization and redensification, presented in a single 3ml syringe. It combines non-crosslinked hyaluronic acid (15mg/ml) with a unique, patented Dermo-Restructuring Complex (8 amino acids, 3 antioxidants, 2 minerals, Vitamin B6) and includes 0.3% lidocaine hydrochloride for enhanced patient comfort. Manufactured by Teoxane Laboratories (Geneva, Switzerland), this product aims to nourish the skin, improve hydration, and restore density for a more radiant complexion, with the 3ml volume facilitating treatment of larger surface areas like the face, neck, and décolleté.

It is indicated for improving the quality of skin showing signs of aging such as fine lines, dullness, and reduced elasticity.

Note: This medical device should only be administered by qualified healthcare professionals experienced in skin revitalization techniques.

Mechanism of Action and Properties

TEOSYAL® PURESENSE REDENSITY I employs a dual-action approach. The non-crosslinked hyaluronic acid provides immediate, deep hydration by attracting water molecules within the dermis. Simultaneously, the Dermo-Restructuring Complex delivers essential nutrients directly to the skin cells. These components (including key amino acids, antioxidants like Glutathione, minerals like Zinc and Copper, and Vitamin B6) are selected for their roles in supporting dermal health, collagen synthesis, cellular function, and antioxidant defense. The integrated lidocaine minimizes discomfort during the microinjection procedure.

This treatment focuses on improving overall skin quality and health rather than significant volume filling. The 3ml syringe allows for efficient coverage of extensive areas in a single treatment session.

Indications and Treatment Protocol

TEOSYAL® PURESENSE REDENSITY I (1x3ml) is indicated for individuals seeking improvements in skin quality parameters, particularly over larger areas, such as:

• Global skin hydration enhancement
• Increased skin density and firmness
• Improved skin texture and smoothness
• Enhanced skin radiance and luminosity
• Softening of fine lines

Common treatment zones include the face, neck, and décolleté. Optimal results are typically achieved through a multi-session protocol, often involving an initial series of treatments spaced several weeks apart, followed by maintenance sessions determined by the practitioner based on clinical response.

Administration involves microinjections into the superficial dermis using appropriate techniques.

Expected Outcomes

Following a recommended treatment course, anticipated outcomes include:

• Visibly improved skin hydration and plumpness across treated areas
• Enhanced skin density and suppleness
• Increased skin radiance and a more uniform complexion
• Softening of fine lines and improved overall skin texture
• A healthier, revitalized skin appearance

Potential Adverse Events

As with any injectable procedure, patients may experience temporary reactions primarily related to the injections. Practitioners should advise patients on potential side effects:

• Common Reactions (Typically Mild and Transient): Small red spots (petechiae), erythema (redness), mild swelling or bruising at injection points, slight itching or tenderness. These generally resolve within a few hours to a few days.
• Less Common/Rare Reactions: Persistent discoloration, inflammation, infection, hypersensitivity reactions (potentially related to HA, complex components, or lidocaine – rare), nodule formation.

Patients should be instructed to report any persistent, severe, or concerning reactions to their practitioner promptly.

Storage Conditions

Store between 2°C and 25°C, protected from light and freezing. Ensure the packaging is intact before use.

Disclaimer: This overview provides general information. Healthcare professionals must consult the full instructions provided with TEOSYAL® PURESENSE REDENSITY I (1x3ml) before administration for comprehensive details regarding indications, contraindications, warnings, precautions, administration techniques, and potential adverse events.